Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

360 o View of a Day Hospital Program Performing Exchange Transfusion and Outpatient Pain Management on Adults with Sickle Cell Disease

Natasha Wright, CRNP, Susan M. Sylvester, RN, Gregory J Kato, MD, Enrico Novelli, MD, Maria Nepa, PA-C, Jude C Jonassaint, RN, Laura De Castro, MD MHSc

Blood (2019) 134 (Supplement_1): 5873.

https://doi.org/10.1182/blood-2019-122397

Published: 2019

Journal Articles

Pharmacokinetics and Pharmacodynamics of Ionis-FXI Rx , an Antisense Inhibitor of Factor XI, in Patients with End-Stage Renal Disease on Hemodialysis

Claudette Bethune, PhD, Michael Walsh, MD, PhD, Bill Jung, PhD, Rosie Yu, PhD, Richard S Geary, PhD, Sanjay Bhanot, MD PhD

Blood (2017) 130 (Supplement 1): 1116.

https://doi.org/10.1182/blood.V130.Suppl_1.1116.1116

Published: 2017

Journal Articles

Outcomes Following Placement of Venous Stents for Treatment of Thrombotic Venous Disease

Karen Breen, MD, Prakash Saha, Narayan Karanunithy, Beverley Hunt, Alexander Cohen, Vickie McDonald, James Uprichard, Michael Fay, MBBCHBAO, FRCPath, Stephen Black

Blood (2017) 130 (Supplement 1): 697.

https://doi.org/10.1182/blood.V130.Suppl_1.697.697

Published: 2017

Journal Articles

Red Cell Exchange: A Concise Review of Indications and Management

Elizabeth Biller, Yong Zhao, Lejla Music-Aplenc, MD, Mary Berg, MD, Lisa N Boggio, MD MS, Theresa Boyd, Kelley Capocelli, Deanna C Fang, Scott A Koepsell, MD, PhD, FCAP, Huy P. Pham, MD, M.P.H., Angela Treml, John Weiss, Geoffrey D. Wool, MD PhD, Beverly W Baron

Blood (2017) 130 (Supplement 1): 4800.

https://doi.org/10.1182/blood.V130.Suppl_1.4800.4800

Published: 2017

Journal Articles

The Anti-Factor XII Antibody AB052 Is Antithrombotic without Hemostatic Impairment in a Primate Model of Extracorporeal Membrane Oxygenation

Michael Wallisch, PhD, Erik I Tucker, PhD, Christina U Lorentz, PhD, Jennifer Johnson, RLATG, Marschelle R Carris, BA, Owen JT McCarty, PhD, Monica T Hinds, PhD, András Gruber, MD

Blood (2017) 130 (Supplement 1): 236.

https://doi.org/10.1182/blood.V130.Suppl_1.236.236

Published: 2017

Journal Articles

Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre

Aditi Khandelwal, MDM, Syed Mahamad, BSc candidate, Jerome M. Teitel, MD, Michelle Sholzberg, MDM, MSc

Blood (2016) 128 (22): 1418.

https://doi.org/10.1182/blood.V128.22.1418.1418

Published: 2016

Journal Articles

Arterio-Venous Fistula Is an Applicable Vascular Access for Erythracytapheresis in Patients with Sickle Cell Disease

Blood (2016) 128 (22): 4856.

https://doi.org/10.1182/blood.V128.22.4856.4856

Published: 2016

Journal Articles

Pharmacokinetics of Idelvion (rIX-FP) in a Patient with Renal Failure

Adam S. Kotowski, MD, Shilpa Jain, MD MPH, Steven John Ambrusko, MD MS, Linda Belling, RN, Karen Kovach, MT, ASCP, SH

Blood (2016) 128 (22): 4957.

https://doi.org/10.1182/blood.V128.22.4957.4957

Published: 2016

Journal Articles

Novel Class of Direct Thrombin Inhibitors Prevent Thrombosis By Inhibiting Fibrinogen Cleavage While Preserving Platelet Function

Mohan Sivaraja, PhD, Sivan Sizikov, PhD, Nichole Sandoval, Kenneth Lin, PhD, Lev Igoudin, Subhadra Dash, MSc, Chengpei Xu, MD PhD, Daniel Clemens, PhD, Angels Estiarte, PhD, Timothy Shiau, PhD, Kevin Short, PhD, David Williams, PhD, Anirban Datta, PhD, David Kita, PhD

Blood (2016) 128 (22): 3834.

https://doi.org/10.1182/blood.V128.22.3834.3834

Published: 2016

Journal Articles

HemobloginA 2 Levels Associate with Lower ESA-Dose in African-Americans with Sickle Cell Trait and End-Stage Kidney Disease

Vimal K. Derebail, MD MPH, Kenneth I. Ataga, MD, Abhijit V Kshirsagar, MD MPH, Micah J. Mooberry, MD, Patrick H Nachman, MD, Nigel S. Key, MB, ChB

Blood (2015) 126 (23): 3407.

https://doi.org/10.1182/blood.V126.23.3407.3407

Published: 2015

Journal Articles

Factor V leiden and Prothrombin Gene Mutations: Differences by Gender

Camila Sahebi, MD, Alice J. Cohen, MD, Mirza Hamza Parvez Mughal

Blood (2012) 120 (21): 5135.

https://doi.org/10.1182/blood.V120.21.5135.5135

Published: 2012

Journal Articles

Antisense Oligonucleotide Mediated Depletion of Factor XI Prevents Vascular Occlusion in An Experimental Thrombosis Model in Primates

Jeff R. Crosby, PhD, Ulla M Marzec, MS, Chenguang Zhao, Dacao Gao, Alexey S Revenko, PhD, Anton Matafonov, MD, David Gailani, MD, Robert MacLeod, Ph.D., Andras Gruber, MD, Stephen Hanson, PhD, Brett P. Monia, PhD

Blood (2011) 118 (21): 2250.

https://doi.org/10.1182/blood.V118.21.2250.2250

Published: 2011

Journal Articles

Apple Domain-Specific Anti-Factor XI Antibodies Inhibit Venous-Type Thrombosis with Improved Hemostatic Safety Profiles Compared to Enoxaparin in Primates

Erik I. Tucker, PhD, Ulla M Marzec, MS, Philberta Y Leung, PhD, Stephen R Hanson, PhD, Prof., Norah G Verbout, PhD, Sawan Hurst, MS, Owen J.T. McCarty, PhD, David Gailani, MD, Andras Gruber, MD

Blood (2011) 118 (21): 1173.

https://doi.org/10.1182/blood.V118.21.1173.1173

Published: 2011

Journal Articles

YM150, An Oral Direct Factor Xa Inhibitor: Combination with Aspirin or Clopidogrel In Arteriovenous Shunt Thrombosis In Rats

Yoshiyuki Iwatsuki, PhD, Chinatsu Sakata, Yumiko Moritani

Blood (2010) 116 (21): 3318.

https://doi.org/10.1182/blood.V116.21.3318.3318

Published: 2010

Journal Articles

A role for factor XIIa–mediated factor XI activation in thrombus formation in vivo

Qiufang Cheng, Erik I. Tucker, Meghann S. Pine, India Sisler, Anton Matafonov, Mao-fu Sun, Tara C. White-Adams, Stephanie A. Smith, Stephen R. Hanson, Owen J. T. McCarty, Thomas Renné, András Gruber, David Gailani

Blood (2010) 116 (19): 3981–3989.

https://doi.org/10.1182/blood-2010-02-270918

Published: 2010

Includes: Supplemental data

Journal Articles

Activity and Safety of Lenalidomide and Dexamethasone in Multiple Myeloma Patients with Advanced Renal Failure: a Spanish Multicenter Retrospective Study.

Monica Roig, Angela Ibañez, Inmaculada García, Juan A. Vera,, MD, Carlos Aguilar, Raquel del Campo, Nicolas Gonzalez, Rafael Martínez, Luis Palomera, Isabel Picon, José N. Rodríguez, Miguel A. Sanz,, MD, PhD, Javier de la Rubia

Blood (2009) 114 (22): 1886.

https://doi.org/10.1182/blood.V114.22.1886.1886

Published: 2009

Journal Articles

Perioperative Outcome of Patients with Acquired Factor X Deficiency Associated with AL Amyloidosis: The Mayo Clinic Experience.

Carrie Thompson, MD, Robert Kyle, MD, Morie Gertz, MD, Martha Lacy, MD, John A. Heit, MD, Rajiv Pruthi, MD, Animesh D. Pardanani, MD

Blood (2007) 110 (11): 3965.

https://doi.org/10.1182/blood.V110.11.3965.3965

Published: 2007

Journal Articles

Dose-Dependent Antithrombotic Effects of Apixaban, an Oral Direct Factor Xa Inhibitor, in Prevention and Treatment of Thrombosis in Rabbit Models of Arteriovenous-Shunt and Venous Thrombosis at Doses That Preserve Hemostasis.

Pancras C. Wong, Earl J. Crain, Donald J. Pinto, Carol A. Watson

Blood (2007) 110 (11): 933.

https://doi.org/10.1182/blood.V110.11.933.933

Published: 2007

Journal Articles

Inhibition of Factor XI Decreases Thrombin Production and Prevents Vascular Occlusion in Experimental Thrombosis in Primates.

Erik I. Tucker, BS, Ulla M. Marzec, MS, Andras Gruber, MD, Stephen R. Hanson, PhD

Blood (2007) 110 (11): 763.

https://doi.org/10.1182/blood.V110.11.763.763

Published: 2007

Journal Articles

β 2 -Glycoprotein I Is a Cofactor for t-PA-Mediated Plasminogen Activation.

Chunya Bu, PhD, Lei Gao, PhD, Weidong Xie, Jianwei Zhang, MD, PhD, Yuhong He, Guoping Cai, PhD, Keith McCrae, MD

Blood (2007) 110 (11): 404.

https://doi.org/10.1182/blood.V110.11.404.404

Published: 2007

NARROW

360 o View of a Day Hospital Program Performing Exchange Transfusion and Outpatient Pain Management on Adults with Sickle Cell Disease

Pharmacokinetics and Pharmacodynamics of Ionis-FXI Rx , an Antisense Inhibitor of Factor XI, in Patients with End-Stage Renal Disease on Hemodialysis

Outcomes Following Placement of Venous Stents for Treatment of Thrombotic Venous Disease

Red Cell Exchange: A Concise Review of Indications and Management

The Anti-Factor XII Antibody AB052 Is Antithrombotic without Hemostatic Impairment in a Primate Model of Extracorporeal Membrane Oxygenation

Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre

Arterio-Venous Fistula Is an Applicable Vascular Access for Erythracytapheresis in Patients with Sickle Cell Disease

Pharmacokinetics of Idelvion (rIX-FP) in a Patient with Renal Failure

Novel Class of Direct Thrombin Inhibitors Prevent Thrombosis By Inhibiting Fibrinogen Cleavage While Preserving Platelet Function

HemobloginA 2 Levels Associate with Lower ESA-Dose in African-Americans with Sickle Cell Trait and End-Stage Kidney Disease

Factor V leiden and Prothrombin Gene Mutations: Differences by Gender

Antisense Oligonucleotide Mediated Depletion of Factor XI Prevents Vascular Occlusion in An Experimental Thrombosis Model in Primates

Apple Domain-Specific Anti-Factor XI Antibodies Inhibit Venous-Type Thrombosis with Improved Hemostatic Safety Profiles Compared to Enoxaparin in Primates

YM150, An Oral Direct Factor Xa Inhibitor: Combination with Aspirin or Clopidogrel In Arteriovenous Shunt Thrombosis In Rats

A role for factor XIIa–mediated factor XI activation in thrombus formation in vivo

Activity and Safety of Lenalidomide and Dexamethasone in Multiple Myeloma Patients with Advanced Renal Failure: a Spanish Multicenter Retrospective Study.

Perioperative Outcome of Patients with Acquired Factor X Deficiency Associated with AL Amyloidosis: The Mayo Clinic Experience.

Dose-Dependent Antithrombotic Effects of Apixaban, an Oral Direct Factor Xa Inhibitor, in Prevention and Treatment of Thrombosis in Rabbit Models of Arteriovenous-Shunt and Venous Thrombosis at Doses That Preserve Hemostasis.

Inhibition of Factor XI Decreases Thrombin Production and Prevents Vascular Occlusion in Experimental Thrombosis in Primates.

β 2 -Glycoprotein I Is a Cofactor for t-PA-Mediated Plasminogen Activation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only